Article archive / November 2020
Originally published: . Volume 11, No. 11. Source pages: 10.
Three studies showed promising results that certain mouth wash substances can reduce the viral load in the first stage of the Covid19 illness and potentially have beneficial effects on outcomes.
Dr. Sobeen Syed, (@drbeen on uTube) reviewed two in-vitro studies and one in-vivo. In one of the in-vitro studies, researchers showed that Betadine Products demonstrated strong in-vitro virucidal activity, killing 99.99% of the SARS-CoV-2 virus in 30 seconds. The research has been published in the respected Infectious Disease and Therapy Journal on July 8, 2020.
Even though the in vivo study was a small study, about 20 people, all of these subjects in the Betadine gargling group were able to clear the virus 100% by day six. None of those in the control group had cleared the virus by that time, reported Dr. Syed.
Viral load has been associated with progression from the earlier and less dangerous stages of the illness to the second and third stages which are more serious and deadly. T
The products subjected to in-vitro testing were: Betadine antiseptic products, namely solution (10% PVP-I), skin cleanser (7.5% PVP-I), gargle and mouthwash (1.0% PVP-I) and throat spray (0.45% PVP-I).
This article is part of a historical newspaper archive. Read the original issue for its original layout, photographs and graphics.